BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30106358)

  • 21. Impact of proteinuria and glomerular filtration rate on risk of ischaemic and intracerebral hemorrhagic stroke: a result from the Kailuan study.
    Li Z; Wang A; Cai J; Gao X; Zhou Y; Luo Y; Wu S; Zhao X
    Eur J Neurol; 2015 Feb; 22(2):355-60. PubMed ID: 25346321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between Right Unilateral Ultrabrief electroconvulsive therapy and bilateral electroconvulsive therapy in the elderly: a pilot naturalistic observational study.
    Narchal S; Harris AW; Allen B
    Australas Psychiatry; 2018 Aug; 26(4):394-397. PubMed ID: 29609474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample.
    Fernie G; Bennett DM; Currie J; Perrin JS; Reid IC
    Psychol Med; 2014 Oct; 44(14):2985-94. PubMed ID: 25065412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time trends in incidence of pathological and etiological stroke subtypes during 16 years: the Erlangen Stroke Project.
    Kolominsky-Rabas PL; Wiedmann S; Weingärtner M; Liman TG; Endres M; Schwab S; Buchfelder M; Heuschmann PU
    Neuroepidemiology; 2015; 44(1):24-9. PubMed ID: 25659352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report on 3 years' experience in electroconvulsive therapy in bakirkoy research and training hospital for psychiatric and neurological diseases: 2008-2010.
    Canbek O; Menges OO; Atagun MI; Kutlar MT; Kurt E
    J ECT; 2013 Mar; 29(1):51-7. PubMed ID: 23422520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Ischemic and Hemorrhagic Strokes in Occult and Manifest Cancers.
    Andersen KK; Olsen TS
    Stroke; 2018 Jul; 49(7):1585-1592. PubMed ID: 29866752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Cognitive and Psychological Functioning in Post-Electroconvulsive Therapy Patients.
    Miller ML; Luu H; Gaasedelen O; Hahn-Ketter AE; Elmore A; Dezhkam N; Bayless J; Moser DJ; Whiteside DM
    J ECT; 2019 Mar; 35(1):27-34. PubMed ID: 29727307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute embolic stroke after electroconvulsive therapy.
    Lee K
    J ECT; 2006 Mar; 22(1):67-9. PubMed ID: 16633211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients.
    Rhee TG; Sint K; Olfson M; Gerhard T; H Busch S; Wilkinson ST
    Am J Psychiatry; 2021 Dec; 178(12):1089-1097. PubMed ID: 34503341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals.
    Slade EP; Jahn DR; Regenold WT; Case BG
    JAMA Psychiatry; 2017 Aug; 74(8):798-804. PubMed ID: 28658489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Perstimulus asystole during electroconvulsive therapy: Clinical case and critical literature review].
    Roche NC; Raynaud L; Bompaire F; Lucas JJ; Auxéméry Y
    Encephale; 2016 Feb; 42(1):59-66. PubMed ID: 26350554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of stroke in 28,000 patients with celiac disease: a nationwide cohort study in Sweden.
    Ludvigsson JF; West J; Card T; Appelros P
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):860-7. PubMed ID: 21733721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrotic Syndrome is Associated with Increased Risk of Ischemic Stroke.
    Huang JA; Lin CH; Chang YT; Lee CT; Wu MJ
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104322. PubMed ID: 31427188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter hyperintensity load on stroke recurrence and mortality at 1 year after ischemic stroke.
    Ryu WS; Schellingerhout D; Hong KS; Jeong SW; Jang MU; Park MS; Choi KH; Kim JT; Kim BJ; Lee J; Cha JK; Kim DH; Nah HW; Lee SJ; Kim JG; Cho YJ; Lee BC; Yu KH; Oh MS; Park JM; Kang K; Lee KB; Park TH; Park SS; Lee J; Bae HJ; Kim DE
    Neurology; 2019 Aug; 93(6):e578-e589. PubMed ID: 31308151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of electroconvulsive therapy for mood disorders: a clinical review.
    Kolar D
    Evid Based Ment Health; 2017 Feb; 20(1):12-14. PubMed ID: 28053184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroconvulsive therapy as an alternative treatment for obese patients with mood disorders.
    Moss LE; Vaidya NA
    J ECT; 2006 Sep; 22(3):223-5. PubMed ID: 16957541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
    Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Syndrome, Its Components, and Diabetes on 5-Year Risk of Recurrent Stroke among Mild-to-Moderate Ischemic Stroke Survivors: A Multiclinic Registry Study.
    Fang X; Liu H; Zhang X; Zhang H; Qin X; Ji X
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):626-34. PubMed ID: 26725129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.